Zevra Therapeutics, Inc. ZVRA
ZVRA
Zevra Therapeutics, Inc. CRVS
Corvus Pharmaceuticals, Inc. AKBA
Akebia Therapeutics, Inc. PRTA
Prothena Corporation plc OLMA
Olema Pharmaceuticals, Inc. VTYX
Ventyx Biosciences, Inc. RIGL
Rigel Pharmaceuticals, Inc. NAGE
Niagen Bioscience Inc RGNX
REGENXBIO Inc. KALV
KalVista Pharmaceuticals, Inc.
Zevra Therapeutics, Inc. CRVS
Corvus Pharmaceuticals, Inc. AKBA
Akebia Therapeutics, Inc. PRTA
Prothena Corporation plc OLMA
Olema Pharmaceuticals, Inc. VTYX
Ventyx Biosciences, Inc. RIGL
Rigel Pharmaceuticals, Inc. NAGE
Niagen Bioscience Inc RGNX
REGENXBIO Inc. KALV
KalVista Pharmaceuticals, Inc.
Performance
| Periode | ZVRA | CRVS | AKBA | PRTA | OLMA | VTYX | RIGL | NAGE | RGNX | KALV |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -10.30 % | 96.95 % | -54.89 % | 76.50 % | 755.37 % | 229.13 % | 108.17 % | -54.92 % | 50.87 % | 29.60 % |
| YTD | -6.51 % | 54.51 % | -15.00 % | -26.92 % | 543.45 % | 290.65 % | 145.55 % | 16.33 % | 75.83 % | 90.74 % |
| 1Y | -2.96 % | 21.59 % | -12.23 % | -20.78 % | 456.52 % | 271.56 % | 122.20 % | 3.66 % | 61.83 % | 88.83 % |
| 3Y | 81.60 % | 875.58 % | 265.38 % | -82.42 % | 1 438.20 % | -74.39 % | 187.36 % | 325.00 % | -40.48 % | 200.18 % |
| 5Y | -44.06 % | 109.23 % | -46.88 % | -23.68 % | -3.37 % | -60.23 % | 14.64 % | 31.44 % | -68.14 % | -9.38 % |
| 10Y | -97.38 % | -41.12 % | -86.60 % | -86.09 % | -26.86 % | -60.23 % | 20.48 % | 74.18 % | -26.92 % | -63.97 % |
| From the beginning | -95.43 % | -41.12 % | -93.95 % | 38.75 % | -26.86 % | -60.23 % | -93.35 % | -45.51 % | -54.61 % | -78.29 % |